Balance Sheet
Accounts PayablesAccumulated DepreciationAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueNotes PayablesOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Perspective Therapeutics (CATX) Non-Current Deffered Revenue (2024 - 2025)

Historic Non-Current Deffered Revenue for Perspective Therapeutics (CATX) over the last 2 years, with Q3 2025 value amounting to $26.6 million.

  • Perspective Therapeutics' Non-Current Deffered Revenue changed 0.0% to $26.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $26.6 million, marking a year-over-year change of 0.0%. This contributed to the annual value of $26.6 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Perspective Therapeutics reported Non-Current Deffered Revenue of $26.6 million as of Q3 2025, which was down 0.0% from $26.6 million recorded in Q2 2025.
  • In the past 5 years, Perspective Therapeutics' Non-Current Deffered Revenue ranged from a high of $26.6 million in Q1 2024 and a low of $26.6 million during Q1 2024